Transcription factor 3 (TCF3)

Transcription factor 3 (TCF3) is a basic helix-loop-helix (bHLH) E-protein transcription factor encoded by the TCF3 gene in humans. It is essential for the development of B and T lymphocytes and is a master regulator of gene expression during early embryonic patterning, neurogenesis, and cell lineage determination. TCF3 acts by binding to E-box motifs in DNA to control target gene transcription as homodimers or heterodimers. Loss-of-function or chromosomal rearrangements involving TCF3 are implicated in various lymphoid malignancies, particularly acute lymphoblastic leukemia (ALL) when fused with partners such as PBX1 or HLF. TCF3 also interacts with numerous proteins, modulating wider transcriptional programs in immune and neural development, and is involved in metabolic regulation. Its key roles in developmental and disease processes make it a critical, though therapeutically challenging, molecular target

Other names

Transcription factor E2-alphaE2ABHLHB21ITF1TCF-3Immunoglobulin enhancer-binding factor E12/E47Immunoglobulin transcription factor 1Kappa-E2-binding factorVDR interacting repressorE47p75Class B basic helix-loop-helix protein 21VDIRNegative vitamin D response element-binding proteinVitamin D receptor-interacting repressorE2A-HLF fusion transcript proteinHelix-loop-helix protein HE47NOL1-TCF3 fusionAGM8AGM8AAGM8BMGC129647MGC129648

Not applicable/none established for directly targeting drugs; in cases of fusion proteins (e.g., TCF3-PBX1, TCF3-HLF), targeted therapies are being explored, typically via indirect pathway inhibition